# Pharmacogenetic Prediction of Metoprolol Effectiveness

> **NCT02293096** · NA · TERMINATED · sponsor: **University of Colorado, Denver** · enrollment: 462 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** metoprolol succinate
- **GENETIC:** Genotyping
- **PROCEDURE:** CYP2D6 Phenotyping

## Key facts

- **NCT ID:** NCT02293096
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-09
- **Primary completion:** 2017-08-23
- **Final completion:** 2017-08-23
- **Target enrollment:** 462 (ACTUAL)
- **Why stopped:** Study was terminated due to the change in funding.
- **Last updated:** 2021-09-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02293096

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02293096, "Pharmacogenetic Prediction of Metoprolol Effectiveness". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT02293096. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*